In a lipopolysaccharide-induced inflammatory model of depression, escitalopram demonstrated antidepressant and anti-inflammatory effects by significantly reducing the lipopolysaccharide-induced ascend in serum TNF-α in rats [18]. Here, TNF is linked to depressive symptom measurement.